Lataa...
The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis
BACKGROUND/AIM: Patients with HBV-related decompensated cirrhosis (HBV-DeCi) should be treated with potent nucleos(t)ide analogues (NA)[entecavir (ETV) or tenofovir (TDF)]. The aim was the evaluation of safety and efficacy in terms of changes in liver disease course in HBV-DeCi patients treated with...
Tallennettuna:
| Julkaisussa: | Ann Gastroenterol |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hellenic Society of Gastroenterology
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4289983/ https://ncbi.nlm.nih.gov/pubmed/25608681 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|